IBS-D Phase III Ibodutant IRIS-3 Study: uses & side-effects

PatientsLikeMe would like to remind you that your browser is out of date and many features of the website may not function as expected. Please update your browser for more security and a better experience.

Skip over navigation

Filter by patients with:

Start typing to see suggestions

What is IBS-D Phase III Ibodutant IRIS-3 Study?

Category: Others

The IBS-D IRIS-3 study is a clinical trial examining the efficacy and safety of oral ibodutant for women experiencing irritable bowel syndrome with diarrhea.

See patients taking IBS-D Phase III Ibodutant IRIS-3 Study

Last updated: April 26, 2026

There are no evaluations for IBS-D Phase III Ibodutant IRIS-3 Study.

▲ Back to top